Zobrazeno 1 - 10
of 84
pro vyhledávání: '"4-d]pyrimidine"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maryna Kachaeva, Stepan Pilyo, Sergiy Popilnichenko, Andrii Kornienko, Eduard Rusanov, Volodymyr Prokopenko, Vladimir Zyabrev, Volodymyr S. Brovarets
Publikováno v:
Current Chemistry Letters, Vol 7, Iss 4, Pp 101-110 (2018)
Reaction of methyl 2-aryl-5-(chlorosulfonyl)-1,3-oxazole-4-carboxylates with 1H-pyrazol-5-amines and 1H-1,2,4-triazol-5-amines proceeds with the participation of endocyclic aminoazole nitrogen atoms to yield products containing a primary amino group.
Externí odkaz:
https://doaj.org/article/0c7caff22a474872ba7bdfd3aa659e10
Autor:
Hassanali Moradi, Hossein Eshghi, Mahmoud Chamsaz, Abolfazl Darroudi, Fatemeh Dousti, Issa Zakeri Mofrad
Publikováno v:
Iranian Journal of Chemistry & Chemical Engineering, Vol 36, Iss 3, Pp 97-106 (2017)
A simple and rapid solidified vortex assisted 1-undecanol based liquid-liquid microextraction technique was proposed for preconcentration of trace levels of lead ions. The extraction solvent (1-undecanol) was dispersed into the aqueous samples by the
Externí odkaz:
https://doaj.org/article/bb1612fb23af492796110723c44ca682
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ilaria Laurenzana, Antonella Caivano, Francesco La Rocca, Stefania Trino, Luciana De Luca, Francesca D'Alessio, Silvia Schenone, Geppino Falco, Maurizio Botta, Luigi Del Vecchio, Pellegrino Musto
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Molecular targeted therapies are based upon drugs acting on tumors by interfering with specific targets involved in growth and spread of cancer. Many targeted therapies were approved by Food and Drug Administration as standard treatment, others were
Externí odkaz:
https://doaj.org/article/626a72154ca342d08cd52f8c8fcfe89b
Publikováno v:
Molecules, Vol 13, Iss 7, Pp 1501-1517 (2008)
Hydrazonyl bromides 2a,b reacted with active methylene compounds (dibenzoylmethane, acetylacetone, ethyl acetoacetate, phenacyl cyanide, acetoacetanilide, ethyl cyanoacetate, cyanoacetamide and malononitrile) to afford the corresponding 1,3,4,5- tetr
Externí odkaz:
https://doaj.org/article/b45b488de1ad4bb591d8414348550f47
Publikováno v:
Journal of the Serbian Chemical Society, Vol 64, Iss 11, Pp 655-662 (1999)
Reaction of 2 with different reagents, namely formic acid, acetic anhydride and trichloroacetonitrile, yielded pyrazolo[3,4-d]pyrimidine derivatives 3, 5 and 6, respectively. Pyrazolo[3,4-d]pyrimidine m-thiazine(7) and 2,4-(1H,3H)dithione (8) derivat
Externí odkaz:
https://doaj.org/article/7b33e27aeb3943cda051ba09fa8ac0f8
Autor:
Aldo Di Leonardo, Patrizia Cancemi, Silvia Schenone, Marina Massaro, Fabrizio Lo Celso, César Viseras Iborra, Serena Riela, Giancarlo Grossi, Viviana Barra, Giampaolo Barone
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Uncontrolled cell proliferation is a hallmark of cancer as a result of rapid and deregulated progression through the cell cycle. The inhibition of cyclin-dependent kinases (CDKs) activities is a promising therapeutic strategy to block cell cycle of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7107a32ddffa4a0ed3fa1da454d34bea
http://hdl.handle.net/10261/276435
http://hdl.handle.net/10261/276435
Autor:
RANGO, ENRICO
The first part of this thesis essentially focuses on the preclinical characterization of Si306, a pyrazolo[3,4-d]pyrimidine derivative, identified as a very promising anticancer agent. This compound has shown a favorable in vitro and in vivo activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c04aef68a1e2de1d7dec0a3f364bd5f
http://hdl.handle.net/11365/1140389
http://hdl.handle.net/11365/1140389
Autor:
Juliana Lopes Rangel Fietto, Fabrizio Vincenzi, Vittoria Colotta, Marine Sarlandie, Silvia Pasquini, Flavia Varano, Katia Varani, Daniela Catarzi, Audrey Guilbaud, Julie Pelletier, Jean Sévigny, Nicolly Espindola Gelsleichter
Adenosine pathway, including its generating enzyme (CD73) and its receptors represents a key target for cancer immunotherapy. Here we aimed to search for novel compounds able to co-target the CD73 and the A2A adenosine receptor (A2A AR) as dual-block
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19866c35d8bcaa911e8182b760445c31
http://hdl.handle.net/11392/2429494
http://hdl.handle.net/11392/2429494